InvestorsHub Logo
Followers 16
Posts 395
Boards Moderated 0
Alias Born 12/05/2012

Re: hnbadger1 post# 88267

Friday, 11/01/2013 8:41:16 AM

Friday, November 01, 2013 8:41:16 AM

Post# of 130503
Just general info on the topic...

Focus of the patent filed by UMass involving MANF is at B-cell disorders in general. Some of these are not uncommon such as Type 2 diabetes, while others are very rare, such as congenital hyperinsulinism. One source I found referred to this as "anti-diabetes."